HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Activity of Brigatinib in the Setting of Alectinib Resistance Mediated by ALK I1171S in ALK-Rearranged Lung Cancer.

AuthorsKartik Sehgal, Mary Linton B Peters, Paul A VanderLaan, Deepa Rangachari, Susumu S Kobayashi, Daniel B Costa
JournalJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer (J Thorac Oncol) Vol. 14 Issue 1 Pg. e1-e3 (01 2019) ISSN: 1556-1380 [Electronic] United States
PMID29981924 (Publication Type: Case Reports, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Carbazoles
  • Organophosphorus Compounds
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • brigatinib
  • alectinib
Topics
  • Carbazoles (pharmacology, therapeutic use)
  • Female
  • Humans
  • Lung Neoplasms (drug therapy, pathology)
  • Middle Aged
  • Organophosphorus Compounds (pharmacology, therapeutic use)
  • Piperidines (pharmacology, therapeutic use)
  • Protein Kinase Inhibitors (pharmacology, therapeutic use)
  • Pyrimidines (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: